(View a printer-friendly
PDF version of this article)
POLICING ONLINE PHARMACIES: BIOTERRORISM
MEETS THE WAR ON DRUGS
In light of the recent terrorists attacks and
the increasing threat of bioterrorism, many U.S. citizens
have turned to the Internet in an attempt to gather the supplies
needed to protect them and their loved ones. Central to the
effort is the increased purchasing of prescription drugs over
the Internet. This iBrief explores the benefits and risks
to consumers from buying drugs online, and examines recent
initiatives to police the online pharmacy industry.
Introduction
¶
Can the Internet
fight bioterrorism? It may sound far-fetched, but many Americans
are turning to the Internet to do what the federal government
has yet to accomplish - stop the spread of anthrax. Americans
are taking the war on bioterrorism into their own hands, using
online pharmacies to stockpile anthrax antibiotic ciprofloxacin
("Cipro"). Capitalizing on this vigilantism, a number of foreign
websites are promoting and selling Cipro, a prescription drug,
to American consumers. Cipro is the latest example of the
growing online accessibility to powerful drugs without a valid
prescription. In response, the U.S. Food and Drug Administration
("FDA") is cracking down on domestic and foreign websites
illegally selling prescription drugs. On October 31, 2001,
the FDA issued eleven "cyber letters" to websites selling
unapproved and non-prescribed doses of Cipro, warning the
sites that the sale and distribution in the U.S. may be illegal.1 This
article explores the benefits and risks to consumers from
buying drugs online, and examines recent initiatives to police
the online pharmacy industry.
Purchasing Drugs Online: Saving Money Can Be Hazardous
to Your Health
¶
Consumers who
prefer purchasing prescription drugs online point to cost,
convenience, and privacy advantages. Since the price of prescription
drugs in other countries is often lower than in the U.S.,
foreign online pharmacies offer American consumers a low-cost
alternative. Canadians, for example, pay 20%-50% less than
Americans for prescription drugs.2 Not
surprisingly, The Canadian Drugstore, an online pharmacist,
advertises that it "brings Canadian drug prices to the world"
and saves consumers up to 50% on all prescription drugs.3 Many
elderly patients, a pharmacist's best customer, prefer the
convenience of ordering drugs without leaving their home.
Finally, online pharmacies allow consumers to order products
and consult with a pharmacist in the privacy of their homes.
Some of the most popular drugs for online purchases are "lifestyle
drugs," such as Viagra for erectile dysfunction, Propecia
for hair loss, and Xenical for obesity.4 Sometimes,
anonymous consultation with a distant pharmacist is easier
than a visit to the family doctor.
¶
There are two
types of online pharmacies: those that dispense drugs and
those that prescribe and dispense drugs. At dispensing
websites, users create an account by submitting personal information
such as a credit card and insurance policy. Then the user
must submit a valid doctor's prescription. Depending on the
state, the doctor can either call in or e-mail the prescription.
Alternatively, users may fax or mail a written copy of the
prescription to the pharmacy.5 The
online pharmacy then fills and delivers the prescription.
Some online pharmacies ship products from a central distribution
point, while others partner with local brick-and-mortar pharmacies
for customer pick-up. Prescriptions are usually delivered
within three days at no shipping charge, and overnight delivery
may be available for an extra fee. In the U.S., online pharmacies
must be licensed to sell prescription drugs in the state in
which they operate and in those states to which they sell.6 Thus,
legitimate online pharmacies simply dispense drugs based on
a physician's prescription, but add the convenience of home
delivery.
¶
While dispensing
drugs via the Internet is an accepted practice, prescribing
drugs over the Internet creates significant health risks to
consumers.7 At
prescribing websites, consumers obtain prescription drugs
merely by answering a questionnaire. The Internet pharmacist
is given little information about the patient's current health
status and past medical history. In effect, these sites bypass
the traditional physician-patient relationship in favor of
self-diagnosis.8 Avoiding
meaningful interaction with this "learned intermediary" exposes
consumers to harmful side effects from inappropriately prescribed
medicines and dangerous drug interactions.9 Also,
self-diagnosis delays a patient's decision to seek necessary
medical treatment.10 Worse
yet, some foreign sites, like the ones targeted by the FDA
most recently, require neither a prescription nor a questionnaire
from users.11 Products
on these sites may be legal in other countries, but not approved
for use in the U.S.12 Generally,
prescription drugs available from a foreign pharmacy are either
products for which there are no U.S. counterparts or foreign
versions of FDA-approved drugs.13 Since
foreign websites are not subject to FDA regulation, consumers
potentially suffer harm from contaminated, counterfeit, or
outdated drugs. Furthermore, these loose standards facilitate
supply to the prescription drug black market and ease the
way for addicts to import their drugs of choice. Given these
health and safety risks, the federal government is giving
serious attention to the availability of prescription drugs
online, both domestically and abroad.
Policing Online Pharmacies: The War on Drugs Takes a
New Twist
¶
Although online
sales of Cipro are a recent development, concern over the
illegal sale of prescription drugs is not. The rise of domestic
and foreign online pharmacies has led to increased surveillance
of Internet drug sales, marketing, and distribution. Traditionally,
regulation of drug sales is a state role.14 However,
Internet technology makes state regulation of online pharmacies
challenging. For instance, a consumer in one state, using
an Internet site launched from a computer in a second state,
may order a drug dispensed from a third state, under a prescription
from a doctor in a fourth state.15 Because
of the interstate (and international) nature of Internet commerce,
the federal government plays an active role in regulating
online pharmacies. As the former FDA Commissioner said, "Ironically,
some of the internet's strengths - including anonymity, speed,
and ability to transcend state and international borders -
are also some of the same factors that make enforcement and
policymaking in this area extremely challenging."16 Through
a combined effort of federal agencies, Congressional legislation,
and industry regulation, the U.S. is tackling the consumer
health risks associated with online pharmacies.
¶
The burden of
policing online pharmacies primarily falls on the FDA. Under
the Food, Drug, and Cosmetic Act ("FDCA"), the FDA can take
action against the importation, sale, or distribution of an
adulterated, misbranded, or unapproved drug.17 Furthermore,
the FDA can take action against illegal promotion of a drug,
the sale or dispensing of prescription drugs without a valid
prescription, and counterfeit drugs.18 Prescription
drugs include any drug that is habit-forming or has a toxicity
or method of use that is potentially harmful.19
¶
When the FDA
sent cyber letters to Cipro-selling websites, it was acting
under the Internet Drug Sales Action Plan. The plan, launched
in 1999 to address the health risks of online pharmacies,
focuses FDA enforcement activities on unapproved new drugs,
health fraud, and prescription drugs sold without a valid
prescription.20 Cyber
letters are electronic letters sent by the FDA to offending
foreign websites. They warn companies to cease advertising
and selling prescription or counterfeit drugs to Americans.
Also, cyber letters explain to the offending website the associated
civil and criminal penalties. The FDA sent 58 cyber letters
in 2000, and has already surpassed that number for 2001.21 In
dealing with the Cipro websites, the FDA stated that sale
and distribution in the U.S. may be illegal, because the FDA
was unable to determine whether the imported drugs were made
in accordance with U.S. specifications.22 Regardless
of their product quality, the Cipro sites were selling a prescription
drug without a valid prescription. The FDA can fine offending
companies up to $500,000 for selling a prescription drug to
a person without a valid prescription.23
¶
In addition
to the FDA, the Federal Trade Commission ("FTC") enforces
consumer protection laws that prohibit unfair or deceptive
acts in the marketplace.24 Applying
this power to online pharmacies, the FTC can take action if
a website operator makes false or misleading claims about
the products or services it provides, including medical consultation
in connection with prescribing and dispensing a drug.25 In
the past few years, the FTC has used this power to clamp down
on unwarranted Viagra prescriptions.
¶
Despite these
successes, the FTC recommends new legislation for clear and
prominent disclosure of identifying information for the online
pharmacist.26 In
October 2000, Rep. Tom Bliley introduced the Internet Prescription
Drug Consumer Protection Act of 2000, requiring an online
pharmacy to post visibly its street address, authorized state
of operation, certain prescriber information, and a statement
that it will dispense prescription drugs only upon a valid
prescription.27 The
bill, however, never made it out of committee. In July 2001,
Sen. Paul Wellstone introduced the Personal Prescription Drug
Import Fairness Act.28 This
bill amends the FDCA to allow the importation of prescription
drugs by individuals, subject to the use of an Import Form.
The Import Form discloses the name, address, and telephone
number of the importing consumer, dispensing pharmacy, prescribing
licensed physician, and drug manufacturer.29 However,
the bill requires evidence that treatment began outside the
U.S. and limits the imported dosage to 90 days.30 While
both of these bills improve disclosure for consumers and law
enforcement officials, neither encourages consumers to bypass
local physicians in favor of internet prescriptions.
¶
At the same
time, the pharmacy industry established its own program to
certify online pharmacies. In 1999, the National Association
of Boards of Pharmacy (NABP) started the Verified Internet
Pharmacy Practice Sites (VIPPS) program. VIPPS, a voluntary
program, certifies an online pharmacy's credentials, including
maintenance of state licenses and inspection by NABP-sanctioned
teams.31 Websites
that are awarded VIPPS certification post the VIPPS seal and
a link to the VIPPS website. The VIPPS program assures consumers
that the online pharmacist is reputable. However, because
the program is voluntary, only 12 sites are registered.32 As
a result, the program does little to discourage less reputable
online pharmacies that prescribe drugs from continuing illicit
operations. Furthermore, because it does not apply to foreign
pharmacies, where prices are usually cheaper, the program
may not stem the tide of non-certified imports.
Conclusion
¶
As fears of
bioterrorism spike demand for Cipro, the U.S. is working to
eliminate rogue online pharmacies that prescribe unwarranted
drugs. Although consumers may benefit from international prices
and online anonymity, increased accessibility to prescription
drugs online may prove to do more harm than good. As with
each commercial domain it enters, the Internet brings new
opportunities for businesses and consumers and new challenges
for law enforcement.
By: Mark Sweet
Footnotes
1. FDA Talk Paper: FDA Issues Cyber-Letters to Web Sites
Selling Unapproved Foreign Ciprofloxacin, (November 1,
2001), available at http://www.fda.gov/bbs/topics/ANSWERS/2001/ANS01115.html(last
visited November 20, 2001).
2. Essif, Mason, Prescription drugs are crossing the borders
to buyers, CNN (March 12, 2001), available at http://www.cnn.com/2001/HEALTH/03/12/prescription.drugs/index.html(last
visited November 20, 2001).
3. See http://www.canadiandrugstore.com/default.asp(last
visited November 20, 2001).
4. Jane E. Henney, M.D., E-Regulation and Public Health,
Address Before the 2000 Leonard Davis Institute of Health
Economics University of Pennsylvania Health Policy Seminar
Series (Sept. 29, 2000), available at http://www.fda.gov/oc/speeches/2000/ecommerce.html(last
visited November 20, 2001).
5. For a discussion of fraud practices associated with counterfeiting
doctor prescriptions, see Eric M. Peterson, Doctoring
Prescriptions: Federal Barriers to Combating Prescription
Drug Fraud Against On-line Pharmacies in Washington, 75
Wash. L. Rev. 1331, 1335 (2000).
6. John Henkel, Buying Drugs Online: It's Convenient and
Private, but Beware of 'Rogue Sites', available at
http://www.fda.gov/fdac/features/2000/100_online.html(last
visited November 20, 2001).
7. Kara M. Friedman, Internet Prescribing Limitations
and Alternatives, 10 Ann. Health L. 139, 143 (2001) (describing
the distinction between internet dispensing and prescribing).
8. Janet Woodcock, M.D., Director of the Center for Drug
Evaluation and Research at the U.S. Food and Drug Administration,
Statement Before the House Subcommittee on Oversight and
Investigations, Washington, D.C. (July 30, 1999).
9. Henkel, supra note 6.
10. Friedman, supra note 7, at 146.
11. Henkel, supra note 6.
12. Woodcock, supra note 8.
13. Id.
14. Henney, supra note 4.
15. Woodcock, supra note 8.
16. Henney, supra note 4.
17. Federal Food, Drug, and Cosmetic Act, 21 U.S.C. §§ 301-907
(West 2000) as cited in Friedman, supra note
7, at 147 and Woodcock, supra note 8.
18. 21 U.S.C. § 331 as cited in Friedman, supra
note 7, at 148.
19. Id.
20. Woodcock, supra note 8.
21. Melissa K. Cantrell, The Taming of E-Health: Asserting
U.S. Jurisdiction over Foreign and Domestic Websites,
103 W. Va. L. Rev. 573, 577 (2001).
22. FDA Talk Paper, supra note 2.
23. Eric M. Peterson, Doctoring Prescriptions: Federal
Barriers to Combating Prescription Drug Fraud Against On-line
Pharmacies in Washington, 75 Wash. L. Rev. 1331, 1335
(2000).
24. Friedman, supra note 7, at 149.
25. Id. at 150.
26. Id. at 152-53.
27. Internet Prescription Drug Consumer Protection Act of
2000, H.R. 5476, 106th Cong. (2000).
28. Personal Prescription Drug Import Fairness Act, S. 1229,
107th Cong. § 2 (2001).
29. Id.
30. Id.
31. Henkel, supra note 6.
32. See http://www.nabp.net/vipps/consumer/listall.asp(last
visited November 20, 2001) for a list of currently certified
sites.